C35H33CdN3S4, monoclinic, C12/c1 (no. 15), a = 36.562(2) Å, b = 9.5395(6) Å, c = 19.892(1) Å, β = 103.501(1)°, V = 6746.3 Å3, Z = 8, Rgt(F) = 0.043, wRref(F2) = 0.114, T = 223 K
ABSTRACT. In this work, a new cadmium complex [Cd(L)(CH3COO)2].2H2O (1) with the ligand L, N,N´-bis(...
C36H58Cd2N6O4S8, monoclinic, P21/c (no. 14), a = 7.82927(4) Å, b = 11.64209(5) Å, c = 26.2493(1) Å, ...
C12H24CdN2O4P2S4, monoclinic, P2/n (no. 13), a = 11.7844(2) Å, b = 7.6063(1) Å, c = 13.1965(2) Å, β ...
C42H40CdN4O9, monoclinic, C2/c (no. 15), a = 42.518(6) Å, b = 9.945(2) Å, c = 9.062(1) Å, β = 94.674...
C34H30CdCl2N4O7, monoclinic, P121/c1 (no. 14), a = 13.7555(2) Å, b = 20.4059(3) Å, c = 12.3696(2) Å,...
The CdII atom in the title compound, [Cd(C5H 10NS2)2-(C10H8N 2)], exists in an N2S4 donor set define...
The dinuclear centrosymmetric title compound, [Cd2(C7H14NS2)4(C12H10N4)], features a tetradentate 2-...
C42H30CdN4O4, monoclinic, C2/c (no. 15), a = 9.6025(3) Å, b = 21.6248(5) Å, c = 16.4162(5) Å, β = 96...
The [Cd(C5H5N)2(S2CO-n-C4H9)2] adduct of pyridine with [Cd(S2CO-n-C4H9)2]n was synthesized and chara...
C28H24CdN2O7, monoclinic, P121/c1 (no. 14), a = 8.6880(8) Å, b = 18.893(2) Å, c = 15.585(1) Å, β = 9...
[Cd(C12H13N5)2Cl2], monoclinic, Cc (no. 9), a = 9.3081(2) Å, b = 11.7526(3) Å, c = 24.9876(6) Å, β =...
C27H23N3O5Cd, monoclinic, P21/n (no. 14), a = 9.6161(7) Å, b = 16.5427(11) Å, c = 15.8900(11) Å, β =...
The mononuclear title cadmium complex, [Cd(C10H14N2O)2(C8H4NO2)2(H2O)2], is centrosymmetric and cont...
The CdII atom in the title compound, [Cd(C6H12NS2)2(C10H8N2)], is hexacoordinated by two dithiocarba...
Crystalline bis(N, N-di-iso-butyldithiocarbamato-S,S')(pyridine)cadmium(II) - adduct 1 was prepared ...
ABSTRACT. In this work, a new cadmium complex [Cd(L)(CH3COO)2].2H2O (1) with the ligand L, N,N´-bis(...
C36H58Cd2N6O4S8, monoclinic, P21/c (no. 14), a = 7.82927(4) Å, b = 11.64209(5) Å, c = 26.2493(1) Å, ...
C12H24CdN2O4P2S4, monoclinic, P2/n (no. 13), a = 11.7844(2) Å, b = 7.6063(1) Å, c = 13.1965(2) Å, β ...
C42H40CdN4O9, monoclinic, C2/c (no. 15), a = 42.518(6) Å, b = 9.945(2) Å, c = 9.062(1) Å, β = 94.674...
C34H30CdCl2N4O7, monoclinic, P121/c1 (no. 14), a = 13.7555(2) Å, b = 20.4059(3) Å, c = 12.3696(2) Å,...
The CdII atom in the title compound, [Cd(C5H 10NS2)2-(C10H8N 2)], exists in an N2S4 donor set define...
The dinuclear centrosymmetric title compound, [Cd2(C7H14NS2)4(C12H10N4)], features a tetradentate 2-...
C42H30CdN4O4, monoclinic, C2/c (no. 15), a = 9.6025(3) Å, b = 21.6248(5) Å, c = 16.4162(5) Å, β = 96...
The [Cd(C5H5N)2(S2CO-n-C4H9)2] adduct of pyridine with [Cd(S2CO-n-C4H9)2]n was synthesized and chara...
C28H24CdN2O7, monoclinic, P121/c1 (no. 14), a = 8.6880(8) Å, b = 18.893(2) Å, c = 15.585(1) Å, β = 9...
[Cd(C12H13N5)2Cl2], monoclinic, Cc (no. 9), a = 9.3081(2) Å, b = 11.7526(3) Å, c = 24.9876(6) Å, β =...
C27H23N3O5Cd, monoclinic, P21/n (no. 14), a = 9.6161(7) Å, b = 16.5427(11) Å, c = 15.8900(11) Å, β =...
The mononuclear title cadmium complex, [Cd(C10H14N2O)2(C8H4NO2)2(H2O)2], is centrosymmetric and cont...
The CdII atom in the title compound, [Cd(C6H12NS2)2(C10H8N2)], is hexacoordinated by two dithiocarba...
Crystalline bis(N, N-di-iso-butyldithiocarbamato-S,S')(pyridine)cadmium(II) - adduct 1 was prepared ...
ABSTRACT. In this work, a new cadmium complex [Cd(L)(CH3COO)2].2H2O (1) with the ligand L, N,N´-bis(...
C36H58Cd2N6O4S8, monoclinic, P21/c (no. 14), a = 7.82927(4) Å, b = 11.64209(5) Å, c = 26.2493(1) Å, ...
C12H24CdN2O4P2S4, monoclinic, P2/n (no. 13), a = 11.7844(2) Å, b = 7.6063(1) Å, c = 13.1965(2) Å, β ...
DOI
Add to ORKG